# Durvalumab for Stage III EGFR-Mutated NSCLC After Definitive Chemoradiotherapy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/durvalumab-for-stage-iii-egfr-mutated-nsclc-after-definitive-chemoradiotherapy/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jacqueline V. Aredo,Isa Mambetsariev,Jessica A. Hellyer,Arya Amini,Joel W. Neal,Sukhmani K. Padda,Caroline E. McCoach,Jonathan W. Riess,Elwyn C. Cabebe,Jarushka Naidoo,Tariq Abuali,Ravi Salgia,Billy W. Loo,Maximilian Diehn,Summer S. Han,Heather A. Wakelee |
| Citations | 130 |
| DOI | 10.1016/j.jtho.2021.01.1628 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.jto.org/article/S1556086421017020/pdf |
| OpenAlex ID | https://openalex.org/W3131416308 |
| PMID | 33588109 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Isa Mambetsariev](https://scholariq.org/researchers/isa-mambetsariev/)

## Paper journal

- [Journal of Thoracic Oncology](https://scholariq.org/journals/journal-of-thoracic-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.